发明名称 New 2-amino-4-(heteroarylethyl) thiazoline derivatives having inducible NO-synthase inhibiting activity, useful for treating Parkinson's, cerebral disorders, migraines, depression, diabetes
摘要 2-Amino-4-heteroarylethyl thiazoline derivatives (I), their racemates, enantiomers, and diastereoisomers, their mixtures, tautomers and salts. 2-Amino-4-heteroarylethyl thiazoline derivatives of formula (I), their racemates, enantiomers, and diastereoisomers, their mixtures tautomers and salts. Het = 2-thienyl, 3-thienyl, 2-pyrimidyl, 5-pyrimidyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-thiazolyl, 4-thiazolyl, or 5-thiazolyl. Independent claims are also included for: (1) Preparation of (I); (2) Preparation of an intermediate of formula (II); and (3) 3 Intermediates: N-(tert-butyl)-N'-((1R)-2-hydroxy-1-(2-thien-3-ylethyl)ethyl) thiourea, (2R)-2-amino-4-(3-thienyl)-1-butanol hydrochloride and tert-butyl (4R)-2,2-dimethyl-4-(2-thien-3-ylethyl)oxazolidine-3-carboxylate.
申请公布号 FR2832151(A1) 申请公布日期 2003.05.16
申请号 FR20010014509 申请日期 2001.11.09
申请人 AVENTIS PHARMA SA 发明人 BACQUE ERIC;BIGOT ANTONY;CARRY JEAN CHRISTOPHE;MIGNANI SERGE
分类号 A61P25/00;A61P25/16;A61P29/00;A61P35/00;C07D239/26;C07D277/28;C07D333/20;C07D413/06;C07D417/06 主分类号 A61P25/00
代理机构 代理人
主权项
地址